Hims & Hers Health, Inc. (HIMS)

Healthcare
Drug Manufacturers - Specialty & Generic
United States
Yahoo Finance  •  Trading View  •  Company site
Price
$17.21
▼ -0.04 (-0.20%)
Market Cap
$3,916,692,736
Shares: 225,342,857.143
P/E
N/A
P/B: N/A
ROE
2.72%
Current Ratio: 1.88
Fundamentals Score
30 (NEGATIVE)

Company Overview

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. The company also provides Labs which measures key markers over time and provides doctor-developed action plans. Hims & Hers Health, Inc. is based in San Francisco, California.

Headquarters: 2269 Chestnut Street, San Francisco, CA, 94123, United States  |  Employees: 1637  |  Website: hims.com
Key Contacts
IR / Phone: 415 851 0195
Exchange: NYQ
Industry: Drug Manufacturers - Specialty & Generic
Quick Financial Snapshot
Revenue$598,976,000
Net Income$15,774,000
Free Cash Flow$-738,677,000
Book Value / ShareN/A

Balance Sheet & Liquidity

Total Liabilities$1,652,322,000
Total Equity$580,982,000
Debt / EquityN/A
Current Ratio1.88
Interest CoverageN/A
Working CapitalN/A

Valuation Metrics

Core multiples and valuation signals — useful to compare vs peers.

P/E (TTM)N/A
Industry P/EN/A
Forward P/E15.43
P/BN/A
Price / SalesN/A
P / FCFN/A
EV / EBITDAN/A
Graham NumberN/A
DCF (placeholder)
Notes: red items typically indicate expensive multiples relative to fundamentals. Use the "Compare with industry" tool for context.

EPS (Annual)

Financial Performance

Revenue vs Net Income

Free Cash Flow (annual)

Profitability & Efficiency

Gross Margin 73.80%
Operating Margin N/A
Net Margin N/A
ROIC N/A
Asset Turnover N/A

Automated Fundamental Signals (Score: 30)

Passed
  • Price CAGR 8.25%
  • Gross Margin 73.8%
  • Debt/Equity ratio
  • Current Ratio
Failed
  • EPS shows upward trend
  • EPS CAGR -33.13%
  • Operating Margin 2.0%
  • Positive Free Cash Flow
  • Debt/EBITDA
  • DCF valuation (Overvalued)

Price Chart (Candlestick)

Technical Analysis (Score: 60)

RSI (14)16.06
SMA 5032.07
SMA 20045.64
MACD-3.85
Signal NEUTRAL
RSI 16.1, SMA trend bearish, momentum -60.5%.

Governance & Management

Governance scores: Audit: 2 | Board: 8 | Compensation: 10 | Shareholder Rights: 10
Executive Team
NameTitle
Mr. Andrew Dudum Co-Founder, Chairman & CEO (1988)
Mr. Oluyemi Okupe Chief Financial Officer (1986)
Mr. Mike Chi Chief Operating Officer (1980)
Ms. Soleil Teubner Boughton J.D. Chief Legal Officer & Corporate Secretary (1978)
Dr. Patrick Carroll M.D. Chief Medical Officer & Director (1958)
Ms. Deborah M. Autor J.D. Chief Policy Officer & Director (1967)
Ms. Irene A. Becklund Senior VP, Controller & Principal Accounting Officer (1984)
Mr. Mohamed ElShenawy Chief Technology Officer (1974)
Governance data last updated: 2/1/2026

Latest News

No news available for this company.

← Back